Our results indicate that NAMPT knockdown exerts antiatherogenic effects by promoting macrophage RCT through the PPARα-LXRα pathway, and is consistent with the concept that NAMPT may be a negative regulator of macrophage RCT and the development of atherosclerosis in humans. The gene discussed is PPARA; the disease is atherosclerosis.